What to Expect From Aphria's (APHA) Upcoming Earnings Report

: APHA | Aphria Inc. Common Shares News, Ratings, and Charts

APHA – While most other stocks in the cannabis industry have been reporting losses each quarter, Aphria Inc. (APHA) has bucked the trend. .

 

While most other stocks in the cannabis industry have been reporting losses each quarter, Aphria Inc. (APHA) has bucked the trend.  Aphria Inc. was the first profitable large-cap Canadian cannabis producer in 2019. 

Cannabis investors are hoping to see another solid quarter from Aphria when it releases its quarterly earnings report on January 14th. If Aphria can deliver a solid quarter, it would be great not only for the company but it could bring some much-needed optimism back to the overall cannabis sector.

However, that might not happen.  Canadian marijuana sales are up only slightly over the last few months.  Therefore, it’s not prudent for investors to expect much in the way of upside sales from Aphria.  

As a result, investors are only hoping for sequentially stable revenues from the company. The key to this earnings report is for Aphria to show strong financial targets for its fiscal year that ends in May. 

The challenge Aphria will face is how it will navigate the cannabis market over the next few months because it will be several months before major catalysts kick in that will help the company’s bottom line.

New retail locations in Ontario, Canada don’t plan to open until April. And Cannabis 2.0 products have had slow rollouts and many key Canadian provinces have blocked the sale of vape products.

So in the near term, we could see a guidance cut but the company could maintain strong estimates going into 2021.

Yet, even with these near term challenges, Wall Street analysts are bullish on Aphria.  According to MarketBeat.com, “7 Wall Street analysts have issued ratings and price targets for Aphria in the last 12 months. Their average twelve-month price target is $12.85, suggesting that the stock has a possible upside of 166.60%. The high price target for APHA is $22.75 and the low price target for APHA is $6.50. There are currently 1 sell rating and 6 buy ratings for the stock, resulting in a consensus rating of “Buy.””

We will be watching this earnings release closely, as Aphria is one of our favorite cannabis stocks.  It’s a well managed company that has outperformed its larger competitors and we expect great things from Aphria in the long run.

(Disclosure: The author owns shares of Aphria)

 


APHA shares were trading at $4.94 per share on Friday afternoon, up $0.11 (+2.28%). Year-to-date, APHA has declined -5.36%, versus a 1.17% rise in the benchmark S&P 500 index during the same period.


About the Author: Aaron Missere


Aaron is an experienced investor who is also the CEO of Departures Capital. His primary focus is on the cannabis industry. He also hosts a weekly show on YouTube about marijuana stocks. Learn more about Aaron’s background, along with links to his most recent articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
APHAGet RatingGet RatingGet Rating
CGCGet RatingGet RatingGet Rating
ACBGet RatingGet RatingGet Rating
CRONGet RatingGet RatingGet Rating
GWPHGet RatingGet RatingGet Rating
TLRYGet RatingGet RatingGet Rating
CTSTGet RatingGet RatingGet Rating
MJGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


How Low Could Stocks Go?

The S&P 500 (SPY) is starting to test key support levels for the first time since November 2023 given continuing signs that Fed rate cuts are getting pushed further and further into the future. This begs the question of “how low could stocks go?” 44 year investment veteran Steve Reitmeister does his level best to answer that question including a trading plan and top picks to stay one step ahead of the market. Read on below for the full story...

3 Biotech Stocks to Buy to Power Through April

The biotech sector is primed for growth, fueled by a surge in FDA approvals, anticipated M&A deals, and the integration of AI in drug discovery. So, fundamentally sound biotech stocks Theratechnologies (THTX), Harmony Biosciences (HRMY), and Shionogi & Co. (SGIOY) might be solid buys in this month. Keep reading...

Check out These 3 Internet Stocks for Potential Gains

Amplified internet usage, technological advancements, and a rising digital transformation worldwide have driven the internet industry rapidly. To that end, quality internet stocks Wix.com (WIX), Tripadvisor (TRIP), and Yelp (YELP) could be solid buys now. Read on…

Top 3 Financial Services Stocks With Unstoppable Momentum

The financial services sector is set for solid growth owing to global economic trends, technological advancements making digital services more accessible, and changing consumer preferences.Therefore, investors could consider buying fundamentally strong financial services stocks Broadridge Financial Solutions (BR), Banco Macro (BMA), and Yiren Digital (YRD) as they look well-positioned to continue their momentum. Read more...

Updated 2024 Stock Market Outlook

The bull market continues to rage on with the S&P 500 (SPY) making new highs. That is the past...the question is what does the future hold? That is why 44 year investment veteran Steve Reitmeister provides this updated 2024 Stock Market Outlook to help you carve a path to outperformance the rest of the year. Read on below for the full story...

Read More Stories

More Aphria Inc. Common Shares (APHA) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All APHA News